Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

Objective To determine whether intensive combinations of synthetic disease modifying drugs can achieve similar clinical benefits at lower costs to high cost biologics such as tumour necrosis factor inhibitors in patients with active rheumatoid arthritis resistant to initial methotrexate and other sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, David L, Ibrahim, Fowzia, Farewell, Vern, O’Keeffe, Aidan G, Walker, David, Kelly, Clive, Birrell, Fraser, Chakravarty, Kuntal, Maddison, Peter, Heslin, Margaret, Patel, Anita, Kingsley, Gabrielle H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358851/
https://www.ncbi.nlm.nih.gov/pubmed/25769495
http://dx.doi.org/10.1136/bmj.h1046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358851/
https://www.ncbi.nlm.nih.gov/pubmed/25769495
http://dx.doi.org/10.1136/bmj.h1046

Ejemplares similares